Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 1987Journal of Clinical Oncology

Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.

View Full Paper
Ask AI
Bookmark
Share

Authors

GBGeorge J. BoslMemorial Sloan Kettering Cancer CenterNGNancy L. GellerGeneral CardiologyNVN. VogelzangAstraZeneca (United Kingdom)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bosl et al. (1987) studied this question.

synapsesocial.com/papers/6a912f3ebe68d22e6965e33fhttps://doi.org/10.1200/jco.1987.5.3.436
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prognostic factors for favorable outcome in disseminated germ cell tumors.1986 · 295 citations
  2. 2Successful treatment of resistant germinal neoplasms with VP-16 and cisplatin: results of a Southeastern Cancer Study Group trial.1985 · 146 citations
  3. 3VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.1986 · 202 citations
  4. 4Treatment and Surgical Staging of Testicular and Primary Extragonadal Germ Cell Cancer1983 · 108 citations
  5. 5The results of chemotherapy for extragonadal germ-cell tumors in the cisplatin era: the Memorial Sloan-Kettering Cancer Center experience (1975 to 1982).1985 · 74 citations